An antiapoptotic role for the receptor tyrosine kinase Axl in cutaneous squamous cell carcinoma

An antiapoptotic role for the receptor tyrosine kinase Axl in cutaneous squamous cell carcinoma

Bibliographic Details
Main Authors:	Papadakis, E, Vyas, J, Patel, N, Ghali, L, Storey, A, O'Toole, E
Format:	Conference item
Published:	2009

Similar Items

A role for the receptor tyrosine kinase, Axl, in cutaneous squamous cell carcinoma survival
by: Papadakis, E, et al.
Published: (2008)

A role for the receptor tyrosine kinase, Axl, in squamous cell carcinoma invasion and survival
by: Papadakis, E, et al.
Published: (2008)

A role for the receptor tyrosine kinase Axl in regulating NF-kappa B activity in cutaneous squamous cell carcinomas
by: Papadakis, E, et al.
Published: (2009)

Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.
by: Papadakis, E, et al.
Published: (2011)

The Receptor Tyrosine Kinase AXL in Cancer Progression
by: Erinn B. Rankin, et al.
Published: (2016-11-01)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
by: Andrea Pontara, et al.
Published: (2020-04-01)

Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
by: Mohan Shankar Gopinatha Pillai, et al.
Published: (2023-06-01)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
by: Xinyan Wu, et al.
Published: (2021-08-01)

Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
by: Anna Gustafsson, et al.
Published: (2009-01-01)

Axl receptor tyrosine kinase is a regulator of apolipoprotein E
by: Wenchen Zhao, et al.
Published: (2020-05-01)

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
by: Okimoto RA, et al.
Published: (2015-04-01)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma with loss of type VII collagen
by: Martin, V, et al.
Published: (2008)

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
by: Kristina Breitenecker, et al.
Published: (2023-09-01)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma cells with loss of type VII collagen
by: Martins, V, et al.
Published: (2009)

AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
by: Pardis Mohammadzadeh, et al.
Published: (2023-10-01)

AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
by: Edward T Schmid, et al.
Published: (2016-06-01)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
by: Diana J Uribe, et al.
Published: (2017-01-01)

Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.
by: Martins, V, et al.
Published: (2009)

Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma
by: Alberto Repici, et al.
Published: (2024-02-01)

Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene
by: Jeong-Woong Park, et al.
Published: (2017-10-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
by: Matthew Walters, et al.
Published: (2020-11-01)

Inhibition of AXL receptor tyrosine kinase enhances brown adipose tissue functionality in mice
by: Vissarion Efthymiou, et al.
Published: (2023-07-01)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Xun Hui Yeo, et al.
Published: (2023-06-01)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Yeo, Xun Hui, et al.
Published: (2023)

The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages
by: Lidia Jiménez-García, et al.
Published: (2022-07-01)

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia
by: Mariam Fatima, et al.
Published: (2021-06-01)

Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
by: Markus Lauter, et al.
Published: (2019-06-01)

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
by: Pinato, D, et al.
Published: (2019)

Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
by: Manoj Kumar Kashyap, et al.
Published: (2018-02-01)

Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
by: Liang Gao, et al.
Published: (2023-08-01)

Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
by: Lea Scherschinski, et al.
Published: (2022-01-01)

A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
by: Ahmad Nasimian, et al.
Published: (2023-02-01)

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
by: Nataliya Pidkovka, et al.
Published: (2023-07-01)

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
by: Siyang Yan, et al.
Published: (2019-11-01)

Correction: Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
by: Liang Gao, et al.
Published: (2023-08-01)

Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Xun Hui Yeo, et al.
Published: (2023-07-01)

Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
by: Keisuke Iida, et al.
Published: (2017-12-01)

Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells.
by: Young Sook Kim, et al.
Published: (2012-01-01)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
by: Pinar Kanlikilicer, et al.
Published: (2017-12-01)

AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma
by: Federica Zito Marino, et al.
Published: (2022-12-01)